Issue 42 | March 2017
Amgen is one of the world's leading biotechnology companies, constantly in search of therapies that will improve the lives of those who suffer from serious diseases such as Osteoporosis. This is a degenerative condition in which the bones become fragile and brittle, their strength reduced by as much as 40%.
The condition affects one in three women over the age of 50.
Working in collaboration with AFLAR (Association Francaise de Lutte Anti-Rhumatismale) they wanted to raise awareness of the condition and let potential sufferers know that early screening could help deal with the problem.